Tandem Diabetes Care Reports Second Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Tandem Diabetes Care (TNDM) PT Raised to $28 at Cowen
July 31, 2018 6:25 AM EDTCowen raised its price target on Tandem Diabetes Care (NASDAQ: TNDM) to $28.00 (from $25.00) while maintaining an Outperform rating following beat and raise.
Analyst Doug Schenkel commented, "TNDM posted a big revenue beat and guidance raise; we expect upside to continue through 2019/2020 and increased... More
Tandem Diabetes (TNDM) Misses Q2 EPS by 82c, Revenues Beat; Offers FY18 Revenue Outlook
July 30, 2018 4:16 PM EDTTandem Diabetes (NASDAQ: TNDM) reported Q2 EPS of ($1.17), $0.82 worse than the analyst estimate of ($0.35). Revenue for the quarter came in at $34.1 million versus the consensus estimate of $29.67 million.
Second Quarter 2018 Results
In comparing the second quarter of 2018 to the same period of 2017:
Pump shipments increased 59 percent to 5,447 pumps from 3,427 pumpsSales... More